Akademska digitalna zbirka SLovenije - logo
E-resources
Full text
Peer reviewed
  • DEAD-Box Helicase DDX3X as ...
    Brai, Annalaura; Trivisani, Claudia Immacolata; Poggialini, Federica; Pasqualini, Claudia; Vagaggini, Chiara; Dreassi, Elena

    Journal of medicinal chemistry, 08/2022, Volume: 65, Issue: 15
    Journal Article

    In recent years, globalization, global warming, and population aging have contributed to the spread of emerging viruses, such as coronaviruses (COVs), West Nile (WNV), Dengue (DENV), and Zika (ZIKV). The number of reported infections is increasing, and considering the high viral mutation rate, it is conceivable that it will increase significantly in the coming years. The risk caused by viruses is now more evident due to the COVID-19 pandemic, which highlighted the need to find new broad-spectrum antiviral agents able to tackle the present pandemic and future epidemics. DDX3X helicase is a host factor required for viral replication. Selective inhibitors have been identified and developed into broad-spectrum antivirals active against emerging pathogens, including SARS-CoV-2 and most importantly against drug-resistant strains. This perspective describes the inhibitors identified in the last years, highlighting their therapeutic potential as innovative broad-spectrum antivirals.